Lignans from the bark of Eucommia ulmoides inhibited Ang II-stimulated extracellular matrix biosynthesis in mesangial cells

Chinese Medicine (United Kingdom)

Volumn 9, Issue 1, 2014, Pages

  Li, Zhen yu ^a   Deng, Xiao lan ^b,c   Huang, Wei hua ^b   Li, Ling ^b,d   Li, Hui ^b   Jing, Xian ^b   Tian, Ying ying ^b   Lv, Pei yu ^b   Yang, Tian lun ^a   Zhou, Hong hao ^b   Ouyang, Dong sheng ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c HAIKOU PEOPLE S HOSPITAL   (China)

^d ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE REDUCTASE; ANGIOTENSIN II; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; EUCOMMIA ULMOIDES EXTRACT; FIBRONECTIN; LIGNAN; LOSARTAN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; BARK; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; EXTRACELLULAR MATRIX; IN VITRO STUDY; KIDNEY INJURY; MESANGIUM CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION;

EID: 84896868669     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-9-8     Document Type: Article

References (28)

1. 2009 Annual data report: atlas of end-stage renal disease in the United States. [http://www.usrds.org/2009/slides/indiv/INDEX_CKD.HTML].
2. Lee SB, Kalluri R. Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl 2010, 119:S22-S26.
3. Kagami S. Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury. Clin Exp Nephrol 2012, 16:214-220. 10.1007/s10157-011-0568-0, 3328682, 22134870.
4. Ding G, Zhang A, Huang S, Pan X, Zhen G, Chen R, Yang T. ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR. Am J Physiol Renal Physiol 2007, 293:F1889-F1897. 10.1152/ajprenal.00112.2007, 17881465.
5. Rüster C, Wolf G. Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. J Am Soc Nephrol 2011, 22:1189-1199. 10.1681/ASN.2010040384, 21719784.
6. Brenner BM. Remission of renal disease: recounting the challenge, acquiring the goal. J Clin Invest 2002, 110:1753-1758. 10.1172/JCI17351, 151659, 12488422.
7. Chen XM, Qi W, Pollock CA. CTGF and chronic kidney fibrosis. Front Biosci (Schol Ed) 2009, 1:132-141. 10.2741/s13, 19482689.
8. Lan HY. Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation. Int J Biol Sci 2011, 7:1056-1067. 3174390, 21927575.
9. Gu J, Yan J, Wu W, Huang Q, Ouyang DS. Research progress in aldose reductase. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2010, 35:395-400.
10. Wang JL, Liu EW, Zhang Y, Wang T, Han LF, Gao XM. Validation of a HPLC-tandem MS/MS method for pharmacokinetics study of (+)-pinoresinol-di-beta-D-glucopyranoside from Eucommia ulmoides Oliv extract in rats' plasma. J Ethnopharmacol 2012, 139:337-342. 10.1016/j.jep.2011.10.037, 22134102.
11. Gu J, Wang JJ, Yan J, Cui CF, Wu WH, Li L, Wang ZS, Yu M, Gao N, Liu L, Ouyang DS. Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling. J Ethnopharmacol 2011, 133:6-13. 10.1016/j.jep.2010.08.055, 20817083.
12. Li L, Yan J, Hu K, Gu J, Wang JJ, Deng XL, Li H, Jing X, Li ZY, Ye QF, Ouyang DS. Protective effects of Eucommia lignans against hypertensive renal injury by inhibiting expression of aldose reductase. J Ethnopharmacol 2012, 139:454-461. 10.1016/j.jep.2011.11.032, 22138658.
13. Jiang T, Che Q, Lin Y, Li H, Zhang N. Aldose reductase regulates TGF-beta1-induced production of fibronectin and type IV collagen in cultured rat mesangial cells. Nephrology (Carlton) 2006, 11:105-112. 10.1111/j.1440-1797.2006.00553.x, 16669970.
14. Huang P, Zhang Y, Jiang T, Zeng W, Zhang N. Aldose reductase is a potent regulator of TGF-beta1 induced expression of fibronectin in human mesangial cells. Mol Biol Rep 2010, 37:3097-3103. 10.1007/s11033-009-9887-6, 19847669.
15. Zou L, Wang W, Xu Z, Zhang N, Jiang T. Aldose reductase regulates platelet-derived growth factor-induced proliferation through mediating cell cycle progression in rat mesangial cells. Int J Mol Med 2012, 30:409-416.
16. Zhang Y, Huang P, Jiang T, Zhao J, Zhang N. Role of aldose reductase in TGF-beta1-induced fibronectin synthesis in human mesangial cells. Mol Biol Rep 2010, 37:2735-2742. 10.1007/s11033-009-9811-0, 19760097.
17. National PCoC Chinese Pharmacopoeia 2010, Beijing: China Medical Science and Technology Press, 2010, National PCoC.
18. Liu E, Han L, Wang J, He W, Shang H, Gao X, Wang T. Eucommia ulmoides bark protects against renal injury in cadmium-challenged rats. J Med Food 2012, 15:307-314. 10.1089/jmf.2011.1756, 22181069.
19. Luo LF, Wu WH, Zhou YJ, Yan J, Yang GP, Ouyang DS. Antihypertensive effect of Eucommia ulmoides Oliv. extracts in spontaneously hypertensive rats. J Ethnopharmacol 2010, 129:238-243. 10.1016/j.jep.2010.03.019, 20347950.
20. Liu N, Chen XQ, Du H, Xue XJ, Ouyang DS. Separation and purification of the lignans from Eucommia ulmoides. HuaXue Tong Bao 2006, 69:4.
21. Zhang Q. Sequence analysis of chloroplast maturase K gene of Chinese medical plant Eucommia ulmoides. ShengTai KeXue 2004, 23:141-143.
22. Li ZY, Gu J, Yan J, Wang JJ, Huang WH, Tan ZR, Zhou G, Chen Y, Zhou HH, Ouyang DS. Hypertensive cardiac remodeling effects of lignan extracts from Eucommia ulmoidesoliv. bark - a famous traditional Chinese medicine. Am J Chin Med 2013, 41:801-815. 10.1142/S0192415X13500547, 23895153.
23. Wolf G, Haberstroh U, Neilson EG. Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 1992, 140:95-107. 1886250, 1731533.
24. Block K, Ricono JM, Lee DY, Bhandari B, Choudhury GG, Abboud HE, Gorin Y. Arachidonic acid-dependent activation of a p22(phox)-based NAD(P)H oxidase mediates angiotensin II-induced mesangial cell protein synthesis and fibronectin expression via Akt/PKB. Antioxid Redox Signal 2006, 8:1497-1508. 10.1089/ars.2006.8.1497, 16987006.
25. Huang Y, Wongamorntham S, Kasting J, McQuillan D, Owens RT, Yu L, Noble NA, Border W. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 2006, 69:105-113. 10.1038/sj.ki.5000011, 16374430.
26. Zhang J, Noble NA, Border WA, Huang Y. Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis. Am J Physiol Renal Physiol 2010, 298:F579-F588. 10.1152/ajprenal.00548.2009, 2838590, 20032116.
27. Davis LK, Rodgers BD, Kelley KM. Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line. Endocrine 2008, 33:32-39. 10.1007/s12020-008-9055-0, 2684556, 18392786.
28. Banes-Berceli AK, Shaw S, Ma G, Brands M, Eaton DC, Stern DM, Fulton D, Caldwell RW, Marrero MB. Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells. Am J Physiol Renal Physiol 2006, 291:F116-F121. 10.1152/ajprenal.00502.2005, 16449352.